Additionally, the results indicated a significant increase in the mRNA levels of TGF-β1, collagen I and collagen III in the DM group compared to the control group, and the changes in the expression of these factors were reversed after administration of ranolazine (Figure 2D). The gene discussed is TGFB1; the disease is diabetes mellitus.